Ursodeoxycholic acid therapy in cystic fibrosis liver disease - a retrospective long-term follow-up case-control study - Kappler, M.; Espach, C.; Schweiger-Kabesch, A.; Lang, T.; Hartl, D.; Hector, A.; Glasmacher, C.; Griese, M. (Alimentary pharmacology & therapeutics, 2012)
Keywords: Adolescent; Adult; Biological and medical sciences; Case-Control Studies; Chemical and Drug Induced Liver Injury - etiology; Child; Child, Preschool; Cholagogues and Choleretics - adverse effects; Cholagogues and Choleretics - therapeutic use; Cystic Fibrosis - complications; Cystic Fibrosis - drug therapy; Digestive system; Errors of metabolism; Female; Gastroenterology. Liver. Pancreas. Abdomen; Humans; Infant; Liver Function Tests; Liver. Biliary tract. Portal circulation. Exocrine pancreas; Longitudinal Studies; Male; Medical sciences; Metabolic diseases; Miscellaneous hereditary metabolic disorders; Other diseases. Semiology; Pharmacology. Drug treatments; Retrospective Studies; Ursodeoxycholic Acid - adverse effects; Ursodeoxycholic Acid - therapeutic use; Young Adult; Hepatic fibrosis; Human; Respiratory disease; Metabolic diseases; Hepatic disease; Cystic fibrosis; Case control study; Long term; Retrospective; Genetic disease; Ursodeoxycholic acid; Treatment; Follow up study; Bile acid; Digestive diseases; Pancreatic disease